Lixisenatide dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (10 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 6–8 mcg | 0.01–0.01 mL | 0–0 units0.00–0.00 mL | — |
| 60–75 kg / 132–165 lb | 8–10 mcg | 0.01–0.01 mL | 0–0 units0.00–0.00 mL | — |
| 75–90 kg / 165–198 lb | 9–13 mcg | 0.01–0.01 mL | 0–1 units0.00–0.01 mL | — |
| 90–105 kg / 198–231 lb | 11–15 mcg | 0.01–0.01 mL | 0–1 units0.00–0.01 mL | — |
| >105 kg / >231 lb | 13–17 mcg | 0.01–0.02 mL | 1–1 units0.01–0.01 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Lixisenatide; the elapsed-time column is hidden.
Lixisenatide by goal
Read Lixisenatide's profile and dosing through a specific research-goal lens.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.